FDA Flags Boston Scientific Catheter Recall

The FDA has announced a recall of all Imager II Angiographic Catheters from Boston Scientific Corp (NYSE: BSX) due to a manufacturing defect that compromises patient safety. The defect involves inadequate stabilizing agents in the catheter tip, which could lead to detachment during medical procedures, posing severe health risks. As of July 16, there have been two serious injuries reported linked to this issue, though no deaths. Following the recall announcement, Boston Scientific shares fell 0.25% to $43.81, nearing their 52-week low of $42.20.